Begüm Ergan

Begüm Ergan

Auto-generated profile, based on publicly available information

Begüm Ergan

Department of Pulmonary and Critical Care, Dokuz Eylül University School of Medicine, İzmir, Turkey

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2021 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
SOSimon Oczkowski
Simon Oczkowski
BEBegüm Ergan
Begüm Ergan
LBLieuwe Bos
Lieuwe Bos
MCMichelle Chatwin
Michelle Chatwin
MFMiguel Ferrer
Miguel Ferrer
RSRaffaele Scala
Raffaele Scala
Background: High-flow nasal cannula (HFNC) has become a frequently used noninvasive form of respiratory support in acute settings; however, evidence supporting its use has only recently emerged. These guidelines provide evidence-based recommendations for the use of HFNC alongside other noninvasive forms of respiratory support in adults with acute respiratory failure (ARF). Materials and methodology: The European Respiratory Society task force panel included expert clinicians and methodologists in pulmonology and intensive care medicine. The task force used the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) methods to summarise evidence and develop clinical recommendations for the use of HFNC alongside conventional oxygen therapy (COT) and noninvasive ventilation (NIV) for the management of adults in acute settings with ARF. Results: The task force developed eight conditional recommendations, suggesting the use of 1) HFNC over COT in hypoxaemic ARF; 2) HFNC over NIV in hypoxaemic ARF; 3) HFNC over COT during breaks from NIV; 4) either HFNC or COT in post-operative patients at low risk of pulmonary complications; 5) either HFNC or NIV in post-operative patients at high risk of pulmonary complications; 6) HFNC over COT in nonsurgical patients at low risk of extubation failure; 7) NIV over HFNC for patients at high risk of extubation failure unless there are relative or absolute contraindications to NIV; and 8) trialling NIV prior to use of HFNC in patients with COPD and hypercapnic ARF. Conclusions: HFNC is a valuable intervention in adults with ARF. These conditional recommendations can assist clinicians in choosing the most appropriate form of noninvasive respiratory support to provide to patients in different acute settings.

29 August 2019 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
BEBegum Ergan
Begum Ergan
SOSimon Oczkowski
Simon Oczkowski
BRBram Rochwerg
Bram Rochwerg
ACAnnalisa Carlucci
Annalisa Carlucci
MCMichelle Chatwin
Michelle Chatwin
WWWolfram Windisch
Wolfram Windisch
Background: While the role of acute non-invasive ventilation (NIV) has been shown to improve outcome in acute life-threatening hypercapnic respiratory failure in COPD, the evidence of clinical efficacy of long-term home NIV (LTH-NIV) for management of COPD is less. This document provides evidence-based recommendations for the clinical application of LTH-NIV in chronic hypercapnic COPD patients.Materials and methods: The European Respiratory Society task force committee was composed of clinicians, methodologists and experts in the field of LTH-NIV. The committee developed recommendations based on the GRADE (Grading, Recommendation, Assessment, Development and Evaluation) methodology. The GRADE Evidence to Decision framework was used to formulate recommendations. A number of topics were addressed under a narrative format which provides a useful context for clinicians and patients.Results: The task force committee delivered conditional recommendations for four actionable PICO (target population-intervention-comparator-outcome) questions, 1) suggesting for the use of LTH-NIV in stable hypercapnic COPD; 2) suggesting for the use of LTH-NIV in COPD patients following a COPD exacerbation requiring acute NIV 3) suggesting for the use of NIV settings targeting a reduction in carbon dioxide and 4) suggesting for using fixed pressure support as first choice ventilator mode.Conclusions: Managing hypercapnia may be an important intervention for improving the health outcome of COPD patients with chronic respiratory failure. The task force conditionally supports the application of LTH-NIV to improve health outcome by targeting a reduction in carbon dioxide in COPD patients with persistent hypercapnic respiratory failure. These recommendations should be applied in clinical practice by practitioners that routinely care for chronic hypercapnic COPD patients.

20 August 2024 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
KKKunal Karamchandani
Kunal Karamchandani
Prashant NasaPrashant Nasa
Prashant Nasa
MJMary Jarzebowski
Mary Jarzebowski
DBDavid J. Brewster
David J. Brewster
AJAudrey De Jong
Audrey De Jong
HSHabib Srour
Habib Srour

18 May 2018 in Turkish Thoracic Journal
Verified
Journal Article
Closed access
MAMetin Akgün
Metin Akgün
BEBegum Ergan
Begum Ergan
Turkthoracj, Turkish Thoracic Journal

1 January 2024 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
KWKiki Waeijen-Smit
Kiki Waeijen-Smit
MCMieke Crutsen
Mieke Crutsen
SKSpencer Keene
Spencer Keene
MMMarc Miravitlles
Marc Miravitlles
ECErnesto Crisafulli
Ernesto Crisafulli
FFFrits M. E. Franssen
Frits M. E. Franssen
Background: Exacerbations of COPD (ECOPD) have a major impact on patients and healthcare systems across the world. Precise estimates of the global burden of ECOPD on mortality and hospital readmission are needed to inform policy makers and aid preventive strategies to mitigate this burden. The aims of the present study were to explore global in-hospital mortality, post-discharge mortality and hospital readmission rates after ECOPD-related hospitalisation using an individual patient data meta-analysis (IPDMA) design.Methods: A systematic review was performed identifying studies that reported in-hospital mortality, post-discharge mortality and hospital readmission rates following ECOPD-related hospitalisation. Data analyses were conducted using a one-stage random-effects meta-analysis model. This study was conducted and reported in accordance with the PRISMA-IPD statement.Results: Data of 65 945 individual patients with COPD were analysed. The pooled in-hospital mortality rate was 6.2%, pooled 30-, 90- and 365-day post-discharge mortality rates were 2.0%, 6.4% and 12.2%, respectively, and pooled 30-, 90- and 365-day hospital readmission rates were 11.8%, 26.5% and 38.2%, respectively, with noticeable variability between studies and countries. Strongest predictors of mortality and hospital readmission included noninvasive mechanical ventilation and a history of two or more ECOPD-related hospitalisations <12 months prior to the index event.Conclusions: This IPDMA stresses the poor outcomes and high heterogeneity of ECOPD-related hospitalisation across the world. Whilst global standardisation of the management and follow-up of ECOPD-related hospitalisation should be at the heart of future implementation research, policy makers should focus on reimbursing evidence-based therapies that decrease (recurrent) ECOPD.

13 April 2018 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
BEBegum Ergan
Begum Ergan
JNJacek Nasiłowski
Jacek Nasiłowski
JWJoão Carlos Winck
João Carlos Winck
Noninvasive ventilation (NIV) is currently one of the most commonly used support methods in hypoxaemic and hypercapnic acute respiratory failure (ARF). With advancing technology and increasing experience, not only are indications for NIV getting broader, but more severe patients are treated with NIV. Depending on disease type and clinical status, NIV can be applied both in the general ward and in high-dependency/intensive care unit settings with different environmental opportunities. However, it is important to remember that patients with ARF are always very fragile with possible high mortality risk. The delay in recognition of unresponsiveness to NIV, progression of respiratory failure or new-onset complications may result in devastating and fatal outcomes. Therefore, it is crucial to understand that timely action taken according to monitoring variables is one of the key elements for NIV success. The purpose of this review is to outline basic and advanced monitoring techniques for NIV during an ARF episode.